{
    "1726874089065701666": {
        "attachments": {
            "media_keys": [
                "3_1726874085789986816"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-11-21T08:04:01.000Z",
        "edit_history_tweet_ids": [
            "1726874089065701666"
        ],
        "entities": {
            "hashtags": [
                {
                    "end": 15,
                    "start": 9,
                    "tag": "media"
                },
                {
                    "end": 30,
                    "start": 20,
                    "tag": "investors"
                }
            ],
            "urls": [
                {
                    "description": "Latest press releases, media assets and global media contacts",
                    "display_url": "gsk.to/40NPEY4",
                    "end": 204,
                    "expanded_url": "https://gsk.to/40NPEY4",
                    "images": [
                        {
                            "height": 315,
                            "url": "https://pbs.twimg.com/news_img/1726874093192896512/ikpBAGxl?format=jpg&name=orig",
                            "width": 600
                        },
                        {
                            "height": 150,
                            "url": "https://pbs.twimg.com/news_img/1726874093192896512/ikpBAGxl?format=jpg&name=150x150",
                            "width": 150
                        }
                    ],
                    "start": 181,
                    "status": 200,
                    "title": "Media | GSK",
                    "unwound_url": "https://www.gsk.com/en-gb/media/?linkId=100000227569676",
                    "url": "https://t.co/V4FzuPyRth"
                },
                {
                    "display_url": "pic.twitter.com/u6nDDhjNpm",
                    "end": 228,
                    "expanded_url": "https://twitter.com/GSK/status/1726874089065701666/photo/1",
                    "media_key": "3_1726874085789986816",
                    "start": 205,
                    "url": "https://t.co/u6nDDhjNpm"
                }
            ]
        },
        "id": "1726874089065701666",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 3765,
            "like_count": 15,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 2
        },
        "text": "News for #media and #investors: We\u2019re announcing a major step towards our sustainability ambitions with advancement to phase III trials for our metered dose inhaler. Find out more: https://t.co/V4FzuPyRth https://t.co/u6nDDhjNpm"
    }
}